cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Murdani Abdullah
Contact Email
ina.jghe@gmail.com
Phone
+6285891498517
Journal Mail Official
ina.jghe@gmail.com
Editorial Address
Divisi Gastroenterologi, Departemen Ilmu Penyakit Dalam, FKUI/RSUPN Dr. Cipto Mangunkusumo, Jl. Diponegoro No. 71 Jakarta 10430 Indonesia
Location
Kota adm. jakarta pusat,
Dki jakarta
INDONESIA
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Published by The Indonesian Society for Digestive Endoscopy
ISSN : 14114801     EISSN : 23028181     DOI : -
Core Subject : Health,
Medicine & Pharmacology
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy is an academic journal which has been published since 2000 and owned by 3 Societies: The Indonesian Society of Gastroenterology; Indonesian Association for the Study of the Liver; The Indonesian Society for Digestive Endoscopy. The aim of our journal is to advance knowledge in Gastroenterology, Hepatology, and Digestive Endoscopy fields. We welcome authors for original articles, review articles, and case reports in the fields of Gastroenterology, Hepatology, and Digestive Endoscopy.
Arjuna Subject : Kedokteran - Ilmu Pencernaan
Articles 771 Documents
 69   70   71   72   73 
Diagnostic Approach and Management of Clostridium difficile Infection Hosea, Fransiscus Nikodemus; Fauzi, Achmad
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 24, No 3 (2023): VOLUME 24, NUMBER 3, December, 2023
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/2432023250

Abstract

Clostridium difficile infection (CDI) was first viewed as a nosocomial infection as it is associated with antibiotics administration. But since antibiotics are more frequently to be prescribed in the community setting, clinicians should investigate the probability of all antibiotics-associated diarrhea as CDI.Diagnostic of CDI should be conducted cautiously as the manifestation of CDI varies from asymptomatic to fatal consequences and is associated with morbidity, mortality, recurrence risk, outbreak possibility, and low quality of life. Management of this infection should include infection prevention and control, stopping the offending antibiotics, and administration of specific antimicrobials.Clinicians should also recognize the risk of recurrence and the higher probability of less efficacious specific antimicrobials in each episode of recurrence.
Urinary Gluten Immunogenic Peptides Correlation with Celiac Disease: A Systematic Review Prasetya, Alver; Yonatan, Eric Ricardo; Subagya, Jonathan Christianto; Tansil, Naomi Juwita; Lee, Yeong Yeh; Tenggara, Riki
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 25, No 2 (2024): VOLUME 25, NUMBER 2, August, 2024
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/2522024280

Abstract

ABSTRACTBackground: Celiac disease (CD) is a condition caused by an abnormal immune response to gluten products. The mainstay of treatment is the gluten-free diet (GFD), but despite patients' efforts to avoid gluten products, some inevitably consume gluten. As current methods for monitoring are limited, a better marker is urgently needed. Urinary gluten immunogenic peptide (UGIP) has been shown to correlate with gluten intake and mucosal damage in CD patients. Therefore, the aim of this systematic review is to summarize the evidence on UGIP as a biomarker in CD patients.Method: This systematic review was conducted in accordance with the PRISMA statement guidelines. The literature search was done using PubMed, ProQuest, EBSCOHost, and Google Scholar for relevant journals published up to March 2023. Newcastle Ottawa Scale and Cochrane Risk of Bias were utilized in the quality assessment of the studies. Result: The literature search identified 85 studies. After eliminating irrelevant and duplicated studies, eight studies were included. Detectable UGIP concentration in the urine correlates with the degree of mucosal damage of CD patients (Marsh II-III). Although three observational studies concluded that there is a correlation between gluten intake and UGIP detection, two randomized controlled trials (RCTs) found that UGIP is not reliable for determining adherence to GFD. Furthermore, UGIP concentrations did not correlate with antibody titers and clinical symptoms. Conclusion:  UGIP may be a helpful biomarker for predicting the severity of mucosal damage in CD patients. However, further studies are needed to evaluate its role in predicting adherence to GFD.ABSTRAKLatar belakang: Penyakit Celiac (CD) adalah suatu kondisi yang disebabkan oleh respon imun yang tidak normal terhadap produk gluten. Pengobatan utama adalah dengan diet bebas gluten (GFD). Meskipun pasien berupaya untuk menghindari produk gluten, beberapa pasien dapat secara tidak sengaja mengkonsumsi gluten. Karena pemeriksaan untuk memantau konsumsi gluten masih terbatas, modalitas pemeriksaan yang dapat diandalkan sangat dibutuhkan. Beberapa bukti mengatakan terdapat korelasi antara peptida imunogenik gluten urin (UGIP) dengan asupan gluten serta kerusakan mukosa pada pasien CD. Oleh karena itu, tinjauan sistematis ini bertujuan untuk merangkum bukti tentang UGIP sebagai modalitas pemeriksaan pada pasien CD.Metode: Tinjauan sistematis ini dilakukan sesuai dengan pedoman pernyataan PRISMA. Pencarian literatur dilakukan menggunakan PubMed, ProQuest, EBSCOHost, dan Google Scholar untuk jurnal relevan yang diterbitkan hingga Maret 2023. Newcastle Ottawa Scale dan Cochrane Risk of Bias digunakan dalam penilaian kualitas studi.Hasil: Pencarian literatur mengidentifikasi 85 penelitian. Setelah mengeliminasi studi yang tidak relevan dan duplikat, delapan studi dimasukkan. Konsentrasi UGIP yang terdeteksi dalam urin berkorelasi dengan tingkat kerusakan mukosa pasien CD (Marsh II-III). Meskipun tiga studi observasi menyimpulkan bahwa ada korelasi antara asupan gluten dan deteksi UGIP, dua uji randomized controlled trials (RCT) menemukan bahwa UGIP tidak dapat diandalkan untuk menentukan kepatuhan terhadap GFD. Selain itu, konsentrasi UGIP tidak berkorelasi dengan titer antibodi dan gejala klinis. Kesimpulan: UGIP dapat dipertimbangkan untuk membantu untuk memprediksi tingkat keparahan kerusakan mukosa pada pasien CD. Namun, studi lebih lanjut diperlukan untuk mengevaluasi perannya dalam memprediksi kepatuhan terhadap GFD. 
The Psychometric Hepatic Encephalopathy Score for Diagnosis of Minimal Hepatic Encephalopathy in Liver Cirrhosis Patient Kumbara, Cokorde Istri Yuliandari Krisnawardani; Wibawa, I Dewa Nyoman; Widiana, I Gde Raka
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 25, No 1 (2024): VOLUME 25, NUMBER 1, April, 2024
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/251202440-46

Abstract

Introduction: The psychometric hepatic encephalopathy score (PHES) is a tool that can be considered as a gold standard for detecting minimal hepatic encephalopathy (MHE) in liver cirrhosis patients. The PHES must be standardized based on the local healthy population before it can be used. The purpose of this study is to standardize the PHES with Indonesian local populations and set the cutoff point of PHES so it can be used to detect MHE in liver cirrhosis patients.Methods: PHES were administered to all enrolled subjects, which are healthy subjects and cirrhosis without overt encephalopathy subjects. The PHES consists of 5 psychometric tests. The influencing factors of PHES were assessed, and equations were developed to predict the expected result of each test. Diagnosis of MHE was built upon the deviation from the normal range value of PHES.Results: In total, 236 subjects participated in this research. The influencing factors of PHES of this study were age and education years. With the cutoff point of PHES less than -4, the prevalence of MHE was 37.7%, of which 7.6%, 50%, and 50% had Child-Turcotte-Pugh (CTP) grade A, B, and C respectively.Conclusions: The standardized version of PHES can be used to diagnose MHE in Indonesian liver cirrhosis patients. The PHES in this study were affected by age and education years. MHE was diagnosed if the PHES was less than -4. The incidence of MHE was found to increase along with the increase of the liver disease severity
Change of Gut Microbiota and its Role in Tuberculosis Mustika, Syifa; Michaela, Cleine
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 25, No 2 (2024): VOLUME 25, NUMBER 2, August, 2024
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/2522024336

Abstract

Introduction: Tuberculosis (TB) is a prevalent infectious illness and a leading cause of death globally. An alteration in the microbial communities heightens vulnerability to tuberculosis. The changes mentioned below are responsible for pulmonary disease, as well as a decrease in the body's ability to resist the invasion of harmful external microorganisms or the depletion of beneficial bacteria. Literature review: Adults diagnosed with pulmonary tuberculosis exhibited a stool microbiome that contained a greater abundance of anaerobic microorganisms. This was found to be linked to proinflammatory immunological pathways in the host and was also associated with the severity of tuberculosis. Relapsed tuberculosis was correlated with elevated Actinobacteria and Proteobacteria levels and decreased Bacteroidetes levels. The pathogenesis of Mycobacterium TB infection and the onset of tuberculosis symptoms may be influenced by changes in the gut-lung microbiome axis. Medication availability, efficacy, and adverse effects can be impacted by the gut flora in several ways. Currently, researchers recommend exploring the potential of combining TB medicine with gut-focused probiotics to improve treatment response and outcomes. Conclusion: The microbiome has the potential to be a modifiable risk factor for tuberculosis. The human microbiota may have a role in the development of M. tuberculosis and treatment for tuberculosis can disrupt the balance of microorganisms, leading to dysbiosis, which can in turn impact the host's immune system. Probiotics and postbiotics demonstrate anti-tuberculosis properties, suggesting their ability to address problems arising from the use of various antibiotics.Keywords: Tuberculosis, microbiome, gut-lung axis
The Effect of Perioperative Probiotics or Synbiotics on Postoperative Ileus in Patients Undergoing Abdominal Surgery: An Evidence-based Case Report Fabiani, Helena; Lestari, Wiji
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 25, No 1 (2024): VOLUME 25, NUMBER 1, April, 2024
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/251202476-82

Abstract

Aims: To explore the effects of perioperative probiotics or synbiotics supplementation on postoperative in patients undergoing abdominal surgery.Method: A literature search was conducted on four databases, PubMed, Cochrane, ProQuest, and Scopus, by using MeSH Term. The article selection process was undertaken by screening the titles or abstracts, reviewing the full texts, and determining their compliance with the inclusion and exclusion criteria. Two systematic review/meta-analysis of randomized controlled trial were critically appraised for validity, importance, and applicability.Results: Perioperative probiotics or synbiotics supplementation may contribute to gastrointestinal function recovery, including reducing postoperative ileus in gastrointestinal cancer. Supplementation of probiotics or synbiotics reduced overall postoperative complications in patients undergoing colorectal cancer surgery and did not cause any side effects. However, the administration of probiotics or synbiotics was not associated with the incidence of postoperative ileus.Conclusion: Perioperative probiotics or synbiotics supplementation can be considered in promoting postoperative gastrointestinal function in abdominal surgery. However, their effect on reducing the incidence of postoperative ileus is still inconsistent.
Comparation between Fibroscan and Hepatus for Detecting NAFLD in Patients with Metabolic Dysregulation Sun, Jie-hui; Zhang, Ping-ping; Wang, Kun; Xu, Miao; Sun, Jing; Li, Li
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 25, No 1 (2024): VOLUME 25, NUMBER 1, April, 2024
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/251202411-20

Abstract

Background The clinical application of the innovative instantaneous elasticity and fat attenuation measurement technology, Hepatus, is currently in the evaluation stage. This study aimed to compare the detection performance of Fibroscan and Hepatus in patients with metabolic dysregulation who are "at-risk" for non-alcoholic fatty liver disease (NAFLD).Methods Between January 2021 and April 2021, 149 patients were enrolled in this study. Clinical data were collected, and all patients underwent both Fibroscan and Hepatus assessments to determine liver stiffness measurement (LSM) and attenuation parameters. The correlation between the results obtained from the two transient elastography (TE) devices was analyzed. Receiver operating characteristic curves (ROC) were constructed to compare the diagnostic value of Fibroscan and Hepatus for Hepatic Steatosis Index (HSI)-based NAFLD.Results The detection success rate of Hepatus (100.0%) was higher than that of Fibroscan (96.0%). LSM (r = 0.663, P0.05) and attenuation parameters (r = 0.778, P0.05) obtained by Fibroscan and Hepatus were significantly correlated. Hepatus tended to produce a higher LSM (Hepatus vs. Fibroscan: 6.04 vs. 5.66 kPa, P=0.016) but a lower attenuation parameter than Fibroscan (Hepatus vs. Fibroscan: 264 vs. 277 dB/m, P0.001). The area under the ROC curve for detecting HSI-based NAFLD was 0.811 for Fibroscan and 0.832 for Hepatus.Conclusion Measurements obtained by Fibroscan and Hepatus are strongly correlated, and the diagnostic value of the two TE devices is comparable in detecting HSI-based NAFLD. Hepatus offer a potential TE alternative in NAFLD examination.
Renal Safety of Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B Patients: An Evidence-based Case Report Dewi, Putu Itta Sandi Lesmana; Pamungkas, Kadek Mercu Narapati; Mariadi, I Ketut
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 25, No 2 (2024): VOLUME 25, NUMBER 2, August, 2024
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/2522024368

Abstract

ABSTRACTBackground: Treatment modalities for chronic hepatitis B infection (CHB) are interferon and antiviral. The most commonly used antiviral is tenofovir disoproxil fumarate (TDF), however it is known to have nephrotoxicity. Recently, a new antiviral tenofovir alafenamide (TAF) has been developed, which also inhibits hepatitis B virus (HBV). This study aimed to compare the renal safety of TAF and TDF.Method: Literature searching was conducted in PubMed/Medline and Cochrane databases, with modified keywords as “chronic hepatitis B”, “tenofovir alafenamide”, “tenofovir disoproxil fumarate”, “renal” with BOOLEAN logic. The articles obtained will be selected and will be carried out for critical appraisal about validity, importance, and applicability.Results: Four studies of double-blind randomized-clinical trials (RCT) were obtained for analysis. The antiviral effects of TAF and TDF groups were not significantly different. The increase in serum creatinine of TAF group was significantly smaller than TDF group in three studies (p 0.05). While one study showed no significant difference (p = 0.32). The decrease in eGFR (estimated-Glomerular Filtration Rate) in the TAF group was smaller than TDF in three studies (p 0.001), whereas one study found an increase in eGFR in the TAF group (p = 0.00034). There were no severe side effects found in both study groups.Conclusion: Based on the scientific evidence obtained, TAF has more renal safety than TDF. Although the antiviral effect is not significantly different.  Keywords: chronic hepatitis B, tenofovir alafenamide, tenofovir disoproxil fumarate, renal function
The Effects Between Black Coffee and Mixed Coffee Consumption Towards Gastroesophageal Reflux Disease (GERD) Symptomps Arsanti, Nabila Mayori; Dewi, Rita; Tenggara, Riki; Rensa, Agnes
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 25, No 2 (2024): VOLUME 25, NUMBER 2, August, 2024
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/2522024288

Abstract

Background: Gastroesophageal Reflux Disease (GERD) is a disease characterized by regurgitation of stomach contents into the esophagus. Signs and symptoms of GERD are regurgitation and heartburn. One of the triggers for GERD is coffee consumption.Aims: This study aims to determine differences in the effect of coffee consumption on black coffee drinkers and mixed coffee drinkers on symptoms of GERD.Methods: A cross-sectional study was conducted in Bekasi City and DKI Jakarta using a demographic questionnaire and consumption of black coffee and mixed coffee and the Gastroesophageal Reflux Disease Questionnaire (GERDQ) in Indonesian language. Data analysis used the Mann-Whitney test to test the percentage difference between the dependent variable and the independent variable.Results: This study obtained 195 participants who were analyzed. As much as 50.8% (99 people) consumed mixed coffee and 52.8% (19 people) had GERD and 50.3% (80 people) did not experience GERD. As many as 49.2% (96 people) consumed black coffee and 47.2% (17 people) had GERD and 49.7% (79 people) did not have GERD. The Mann-Whitney test did not show a significant change (Asymp. Sig. 0.790).Conclusion: There is no significant comparison between the effects of coffee consumption on black coffee drinkers and mixed coffee drinkers on GERD symptoms.Keywords: Gastroesophageal Reflux Disease, GERD, Black Coffee, Mixed Coffee
Severity of Liver Injury and Its Relation to Clinical Outcome and Duration of Hospitalization in COVID 19 Patients Kumbara, Cokorde Istri Yuliandari Krisnawardani; Mariadi, I Ketut; Somayana, Gde; Wibawa, I Dewa Nyoman; Sindhughosa, Dwijo Anargha
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 25, No 1 (2024): VOLUME 25, NUMBER 1, April, 2024
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/251202447-52

Abstract

Background: Coronavirus Disease 2019 (COVID-19) can affect not only the respiratory system but also other organs such as the liver. Liver injury tends to occur in severe disease of COVID-19 patients and might contribute to clinical outcomes for patients. This study aimed to find the relationship between the severity of liver injury with clinical outcome and duration of hospitalizations.Methods: This study was a retrospective study of hospitalized COVID-19 patients period April 2020 to April 2021. The inclusion criteria were severe COVID-19 patients who developed a liver injury. The severity of the liver injury was classified into mild, moderate, and severe. The relationship between the severity of liver injury with clinical outcome and duration of hospitalization was analyzed. Univariate and logistic regression were used. Results: 90 samples fill the inclusion criteria. The liver injury severity was statistically significantly related to clinical outcome patients (p= 0.047), which is the increase in liver injury severity resulting in poor clinical outcomes. No significant relationship was found between the severity of liver injury with the duration of hospitalization.Conclusion: liver injury increases mortality in severe COVID-19 patients.
Annona muricata Leaves Extract Inhibit Carcinogenesis and Regulates Inflammatory Responses in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice Indrawati, Lili; Kusmardi, Kusmardi
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 25, No 2 (2024): VOLUME 25, NUMBER 2, August, 2024
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/2522024309

Abstract

Background: Colon cancer is a major public health problem. The present study was conducted to determine the inhibitory effect of Annona muricata leaves on carcinogenesis and inflammation in the colorectal preneoplasia development of mice.Methods: The effect of Ethanol Insoluble Fraction of Annona muricata water extract (EIFAM) was examined on the preneoplastic lesions (aberrant crypt foci), polyps and tumors induced by the carcinogenic agent azoxymethane (10 mg/kg), followed by administered of 1% DSS during a week in drinking water. (EIFAM)was administered orally in three different doses (200 mg/kgBW (low dose), 400 mg/kgBW (medium dose), and 800 mg/kgBW (high dose)) in each group of mice per day until the mice were terminated. The expression of Caspase, COX-2, and β-catenin were observed in the epithelial cells of colon mucosa crypts.Results: The effects of the extract on various organs’ inflammatory markers varies. COX lowering effect of high dose is significant in liver. Medium dose has significant catenin lowering effect on jejenum, colon, and brain. While the medium and high dose have significant catenin lowering effect on duodenum, heart, and kidney respectively. Histological assessment was done in a blinded fashion to avoid bias. Our results indicate that multiple organ dysplasia was induced with azoxymethane (AOM) in male Swiss Webster mice. The effect of A. muricata extract administration showed significant result only on heart. The activity of caspase showed no significant effect on all organs when treated with the extracts as compared to untreated group.Conclusions: Ethanol-insoluble fraction of Annona muricata (EIFAM) leaves water extract is potential to be an anti-colon cancer proven by the extract capability to reduce inflammatory responses.

Page 71 of 78 | Total Record : 771

 69   70   71   72   73 

Filter by Year

2000 2025


Reset
Filter By Issues
All Issue Vol 26, No 2 (2025): VOLUME 26, NUMBER 2, AGUSTUS, 2025 Vol 26, No 1 (2025): VOLUME 26, NUMBER 1, April, 2025 Vol 25, No 3 (2024): VOLUME 25, NUMBER 3, December, 2024 Vol 25, No 2 (2024): VOLUME 25, NUMBER 2, August, 2024 Vol 25, No 1 (2024): VOLUME 25, NUMBER 1, April, 2024 Vol 24, No 3 (2023): VOLUME 24, NUMBER 3, December, 2023 Vol 24, No 2 (2023): VOLUME 24, NUMBER 2, August, 2023 Vol 24, No 1 (2023): VOLUME 24, NUMBER 1, April, 2023 Vol 23, No 3 (2022): VOLUME 23, NUMBER 3, December 2022 Vol 23, No 2 (2022): VOLUME 23, NUMBER 2, August 2022 Vol 23, No 1 (2022): VOLUME 23, NUMBER 1, April 2022 Vol 22, No 3 (2021): VOLUME 22, NUMBER 3, December 2021 Vol 22, No 2 (2021): VOLUME 22, NUMBER 2, August 2021 Vol 22, No 1 (2021): VOLUME 22, NUMBER 1, April 2021 Vol 21, No 3 (2020): VOLUME 21, NUMBER 3, December 2020 Vol 21, No 2 (2020): VOLUME 21, NUMBER 2, August 2020 Vol 21, No 1 (2020): VOLUME 21, NUMBER 1, April 2020 Vol 20, No 3 (2019): VOLUME 20, NUMBER 3, December 2019 Vol 20, No 2 (2019): VOLUME 20, NUMBER 2, August 2019 Vol 20, No 1 (2019): VOLUME 20, NUMBER 1, April 2019 Vol 19, No 3 (2018): VOLUME 19, NUMBER 3, December 2018 Vol 19, No 2 (2018): VOLUME 19, NUMBER 2, August 2018 Vol 19, No 1 (2018): VOLUME 19, NUMBER 1, April 2018 Vol 18, No 3 (2017): VOLUME 18, NUMBER 3, DECEMBER 2017 Vol 18, No 2 (2017): VOLUME 18, NUMBER 2, AUGUST 2017 Vol 18, No 1 (2017): VOLUME 18, NUMBER 1, April 2017 Vol 17, No 3 (2016): VOLUME 17, NUMBER 3, December 2016 Vol 17, No 2 (2016): VOLUME 17, NUMBER 2, August 2016 Vol 17, No 1 (2016): VOLUME 17, NUMBER 1, April 2016 Vol 16, No 3 (2015): VOLUME 16, NUMBER 3, December 2015 Vol 16, No 2 (2015): VOLUME 16, NUMBER 2, August 2015 Vol 16, No 1 (2015): VOLUME 16, NUMBER 1, April 2015 Vol 15, No 3 (2014): VOLUME 15, NUMBER 3, December 2014 Vol 15, No 2 (2014): VOLUME 15, NUMBER 2, August 2014 Vol 15, No 1 (2014): VOLUME 15, NUMBER 1, April 2014 VOLUME 14, NUMBER 3, December 2013 VOLUME 14, NUMBER 2, August 2013 VOLUME 14, NUMBER 1, April 2013 VOLUME 13, NUMBER 3, Desember 2012 VOLUME 13, NUMBER 2, August 2012 VOLUME 13, NUMBER 1, April 2012 VOLUME 12, NUMBER 3, December 2011 VOLUME 12, NUMBER 2, August 2011 VOLUME 12, NUMBER 1, April 2011 VOLUME 11, NUMBER 3, December 2010 VOLUME 11, NUMBER 2, August 2010 VOLUME 11, NUMBER 1, April 2010 VOLUME 10, NUMBER 3, December 2009 VOLUME 10, ISSUE 2, August 2009 VOLUME 10, ISSUE 1, April 2009 VOLUME 9, ISSUE 3, December 2008 VOLUME 9, ISSUE 2, August 2008 VOLUME 9, ISSUE 1, April 2008 VOLUME 8, ISSUE 3, December 2007 VOLUME 8 ISSUE 2 August 2007 VOLUME 8, ISSUE 1, April 2007 VOLUME 7, ISSUE 3, December 2006 VOLUME 7, ISSUE 2, August 2006 VOLUME 7, ISSUE 1, April 2006 VOLUME 6, ISSUE 3, December 2005 VOLUME 6, ISSUE 2, August 2005 VOLUME 6, ISSUE 1, April 2005 VOLUME 5, ISSUE 3, December 2004 VOLUME 5, ISSUE 2, August 2004 VOLUME 5, ISSUE 1, April 2004 VOLUME 4, ISSUE 3, December 2003 VOLUME 4, ISSUE 2, August 2003 VOLUME 4, NUMBER 1, April 2003 VOLUME 3, NUMBER 3, December 2002 VOLUME 3, NUMBER 2, August 2002 VOLUME 3, NUMBER 1, April 2002 VOLUME 2, NUMBER 3, December 2001 VOLUME 2, NUMBER 2, August 2001 VOLUME 2, NUMBER 1, April 2001 VOLUME 1, NUMBER 1, December 2000 More Issue